sitcancer.orgSITC Cancer Immunotherapy CONNECT - Society for Immunotherapy of Cancer (SITC)

’);//]] ’);//]] ’);function WebForm_OnSubmit() { null; return true; } //]] This website uses cookies to deliver to you the best experience possible on SITC CONNECT. By continuing to use this site, you are providing to us your consent to ensure you receive such an experience. View our privacy policy to learn more. OK Search Options Join SITC Renew Make a Gift (Press Enter). Sign in(Press Enter). Subscribe(Press Enter). Toggle navigation Educational & Scientific Programs ConnectED Advances in Cancer Immunotherapy Collaborative Education Programs Patient and Survivor Education and Resources Webinars and Online Education Advances in Cancer Immunotherapy (ACI) Webinars Definitions, End Points, and Clinical Trial Designs for Bladder Cancer Expanding Access to Cellular and Bispecific Therapies 2024 Glyco-Immunology Webinar Series Immunomodulation of ADCs Virtual Summit Intralesional Virtual Summit Immune Exclusion Virtual Summit Immunoprevention Virtual Summit SITC Clinical Practice Guidelines Online Education AI in IO: SITC-NCI Computational IO Series Targets for Cancer IO: A Deep Dive Series Calendar of Events Annual Meeting & Pre-Conference Programs 39th Annual Meeting & Pre-Conference Programs Past and Future Annual Meetings & Pre-Conference Programs Cancer Immunotherapy Winter School SITC Immuno-oncology Drug Development Summit Spring Scientific 2024 Spring Scientific Past and Future Spring Scientific Programs Workshops Tumor Immune Microenvironment: A Holistic Approach Surfaceome Virtual Workshop Bispecific T cell Engagers Virtual Workshop Cytokines in Cancer Immunotherapy Virtual Workshop Call for Proposals Professional Development & Training Certificate in Cancer Immunotherapy Professional Interest Communities Fellowships Women in Cancer Immunotherapy Network (WIN) Women in Cancer Immunotherapy Network 2024 Women in SITC Community Early Career Scientist (ECS) Committee Clinical Trials Training and Resources SITC Clinical Immuno-Oncology Network (SCION) Workshop Maximizing the Value of Phase III Trials in Immuno-Oncology Definitions, End Points, and Clinical Trial Designs for Bladder Cancer Intratumoral Immunotherapy Clinical Trial (IICT) Design NCI Immunotherapy Fellowship SITC Sparkathon Sparkathon 2024 Support Sparkathon Other Resources Calendar of Events Path to SITC Leadership Publications & Guidelines Journal for ImmunoTherapy of Cancer About JITC Become a Reviewer For Authors From the Editors JITC Collections and Special Issues SITC Immunotherapy Books SITC’s Guide to Managing Immunotherapy Toxicity Textbook Cancer Immunotherapy Principles and Practice Textbook, 2nd Ed. SITC Scientific Publications News SITC Clinical Practice Guidelines Clinical Practice Guidelines Clinical Practice Guidelines Online Education Clinical Practice Guidelines Mobile App SITC Cancer Immunotherapy Guideline News Patient Resource Guides Access & Advocacy SITC Immuno-oncology Drug Development Summit Policy Advocacy News Global Immunotherapy Access Increasing Access to IO: A Global Webinar Series Crisis in Clinical Research Expanding Access to Cellular and Bispecific Therapies Patient & Survivor Education & Resources Membership 2024 SITC Election Connect-a-Colleague Volunteer Volunteer with SITC Academy of Immuno-Oncology About the Academy Corporate Membership Benefits, Categories & Application Members Only SITC Member Directory Support SITC The Forward Fund Moving the Field Forward Making a Difference Named Funds and Awards Early Career Scientist Awards Richard V. Smalley Memorial Award and Lectureship Steven A. Rosenberg Scholars Award Technology Awards Martin "Mac" Cheever Travel Award Fund Sparkathon The CheckPoints: SITC’s House Band Ways to Make a Gift Donate Stocks and Securities Estate and Planned Gifts Corporate Support and Giving Opportunities Corporate Giving Opportunities Corporate Membership Educational Grants Sponsorship & Advertising SITC Merchandise Honor and Memorial Gifts Make a Gift in Honor of a Loved One Make a Gift in Memory of a Loved One Our Donors and Supporters 2022 SITC Supporters Forward Fund Donors About SITC Awards and Recognition Career Connections SITC’s DEI Strategy Elevating a Rich Oncology Community: SITC’s DEI Strategic Plan Virtual Roundtable on Diversity in Clinical Trial Enrollment Partnerships Contact SITC Board of Directors Committees, Task Forces and Professional Interest Communities Mission & Vision Media Room SITC Press Releases Scientific Meeting Highlights from SITC Immune Monitor Archive JITC Digest Archive Cancer Immunotherapy Month SITC Policies The Connect Community Create Account My Profile My Communities My Libraries The Sentinel - SITC Blog SITC Cancer Immunotherapy CONNECT SITC 2024 Abstract Submissions are Open Abstract submissions are now open for Regular, Young Investigator Award (YIA) and Immune Engineering Abstracts. Submit your ground-breaking research for consideration as an oral or poster abstract presentation at SITC 2024. Submit Your Abstract 2024 SITC Election Now Open! SITC is leading the path to IO discovery and will elect a new Vice President and three At-Large Directors to guide the society forward. The election closes on May 16, 2024 at 11:59 p.m. EDT . Learn More SITC Immuno-oncology Drug Development Summit Join us from Sept. 30–Oct. 1, 2024, in Boston at The Revere Hotel Boston Common. The SITC Immuno-oncology Drug Development Summit will educate the IO community on the regulatory paths for the next wave of IO therapeutics. View Program Details Nominate an Emerging Leader in IO SITC is seeking the best and brightest for the 2024 Steven A. Rosenberg Scholars Award, one of the society’s most prestigious opportunities for early career scientists. Nominations are due July 15, 2024 . LEARN MORE The CheckPoints at Buddy Guy’s Legends in Chicago The CheckPoints return to Buddy Guy’s Legends in Chicago (700 S. Wabash Ave.) on June 2, 2024 . The CheckPoints: Rockin’ for a Cure supports SITC’s Forward Fund, which benefits the next generation of cancer immunotherapy experts. LEARN MORE 2024 Advances in Cancer Immunotherapy: A Focus on Toxicity Management May 14, 2024 | 11 A.M.–3 P.M. ET | Virtual Understand toxicities associated with immune checkpoint inhibitors with insights from an expert panel. FREE for healthcare professionals, students, patients and patient advocates. Learn More and Register Targets for Cancer IO: A Deep Dive Series SITC is pleased to announce its fourth Targets for Cancer IO: A Deep Dive live webinar series. At the time of registration, if you buy 4 webinars, you get the remaining 3 for free! REGISTER NOW AI in IO: SITC-NCI Computational Immuno-oncology Webinar Series SITC is pleased to announce its fourth SITC-NCI Computational Immuno-oncology Webinar Series. This year’s series will focus specifically on the application of artificial intelligence (AI) in the field of immuno-oncology (IO). REGISTER NOW Regular and Emeritus Members: Vote in the 2024 SITC Election. Cast Your Vote Advances in Cancer Immunotherapy™ (ACI) Series ACI programs are certified for CME, CNE, CPE, and MOC credits. ACI’s offer in-depth clinical training in immunotherapy treatment for a variety of disease states and topics. ACI webinars are FREE for healthcare professionals, students, patients and patient advocates. Explore the 2024 ACI Series Targets for Cancer IO: 2024 Deep Dive - A Deep Dive into Personalized Vaccines Live Webinar 2 Starts Wednesday, May 22, 2024, from 12–2 p.m. EDT Key leaders in the field who are experts in their respective fields will provide an overview of the current state of the science and address questions about its future. Register Today Advances in Cancer Immunotherapy™: A Focus on Genitourinary Cancers Tuesday, June 11 |11 a.m.–3 p.m. ET Virtual – Zoom Access the latest developments in immunotherapy for kidney and bladder cancers and rare GU tumors. FREE for healthcare professionals, students, patients and patient advocates. Explore Program Advances in Cancer Immunotherapy™: A Focus...